SPONSOR

Vastra Gotaland Region

Total Trials

Recruiting

Phases

Phase 2, Phase 3

Conditions studied: Aortic Aneurysm, Abdominal Renal Insufficiency Stent-Graft Thrombosis Chest Pain Acute Coronary Syndrome Chest--Diseases Recipients of Allogeneic Stem Cell Transplantation HPV (Human Papillomavirus)-Associated Acute Myeloid Leukaemia Myelodysplastic Syndrome

Vastra Gotaland Region is a clinical research sponsor with 19 registered studies on ClinicalTrials.gov, of which 19 are actively recruiting participants. Research covers conditions including Aortic Aneurysm, Abdominal, Renal Insufficiency, Stent-Graft Thrombosis, Chest Pain.

The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Vastra Gotaland Region

How many clinical trials has Vastra Gotaland Region sponsored?

ClinicalMetric currently tracks 19 clinical trials sponsored by Vastra Gotaland Region, of which 19 are actively recruiting participants. These trials cover conditions including Aortic Aneurysm, Abdominal, Renal Insufficiency, Stent-Graft Thrombosis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Vastra Gotaland Region research focus on?

Vastra Gotaland Region clinical trials span Aortic Aneurysm, Abdominal, Renal Insufficiency, Stent-Graft Thrombosis, Chest Pain, Acute Coronary Syndrome, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Vastra Gotaland Region clinical trial?

To participate in a Vastra Gotaland Region trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Vastra Gotaland Region trials with current recruitment status updated daily.

Vastra Gotaland Region

Frequently Asked Questions — Vastra Gotaland Region

Clinical Trials by Vastra Gotaland Region

Renal Function After Stentgraft Treatment Of Abdominal Aortic Aneurysm

Digital Decision Support in the Management of Patients With Chest Pain

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients

Parents of Children With Constipation Will be Asked About Their Views on Their Children's Physical Activity.

Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer

Long-term Health and Economic Effects of an Individualized Lifestyle Intervention (LI-PAD-Extended)

Comparing Upper Limb Surgery and Botulinum Toxin for Spasticity: A Paired Design Study

Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy

Improving Heart and Metabolic Health in People With Severe Mental Illness Through a Long-term Clinical Trial

Individualized Physical Activity or Patients With Non Functioning Pituitary Adenoma

Validating Immunological Markers Associated With Mental Fatigue in Graves' Disease

A Comparison of Morbidity Between Patients With Pulmonary Atresia With Intact Ventricular Septum and Uni- or Biventricular Circulation

Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

Effect of Breast Implants om Mammography Screening

Multidisciplinary Management of Severe COPD

Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant

Course for Brain Fatigue After Graves' Disease Controlled Study

Sentinel Lymph Node Localisation With an Ultra-low Dose of Magtrace in Breast Cancer Patients